BMO Capital analyst John McNulty downgraded Ingevity to Market Perform from Outperform with a price target of $60, down from $71. The analyst says headwinds in the crude tall oil market are more extreme than feared. The company appears to have an effective longer-term strategy to deal with these pressures, but its “earnings hole” tied to the issues will be worse than feared over the next 12-18 months, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NGVT:
- Ingevity cuts FY23 revenue view to $1.6B-$1.7B, consensus $1.82B
- Ingevity reports Q2 adjusted EPS $1.41, consensus $1.37
- Meta Platforms upgraded, Estee Lauder downgraded: Wall Street’s top analyst call
- Ingevity upgraded to Buy from Hold at Loop Capital
- NGVT Upcoming Earnings Report: What to Expect?